{"id":"https://openalex.org/W2015138269","doi":"https://doi.org/10.1111/j.1527-3458.2006.00167.x","title":"Pharmacological Profile of the 5\u2010HT2C Receptor Agonist WAY\u2010163909; Therapeutic Potential in Multiple Indications","display_name":"Pharmacological Profile of the 5\u2010HT2C Receptor Agonist WAY\u2010163909; Therapeutic Potential in Multiple Indications","publication_year":2006,"publication_date":"2006-09-01","ids":{"openalex":"https://openalex.org/W2015138269","doi":"https://doi.org/10.1111/j.1527-3458.2006.00167.x","mag":"2015138269","pmid":"https://pubmed.ncbi.nlm.nih.gov/17227285","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6506193"},"language":"en","primary_location":{"id":"doi:10.1111/j.1527-3458.2006.00167.x","doi":"https://doi.org/10.1111/j.1527-3458.2006.00167.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1527-3458.2006.00167.x","pdf_url":null,"source":{"id":"https://openalex.org/S165828461","display_name":"CNS Drug Reviews","issn_l":"1080-563X","issn":["1080-563X","1527-3458"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drug Reviews","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6506193","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020738134","display_name":"John Dunlop","orcid":"https://orcid.org/0000-0003-2741-6383","observed_orcids":["https://orcid.org/0000-0003-2741-6383"]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John Dunlop","raw_affiliation_strings":["Discovery Neuroscience, Wyeth Research, Princeton, NJ 08543, USA. dunlopj@wyeth.com","Wyeth Research, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Neuroscience, Wyeth Research, Princeton, NJ 08543, USA. dunlopj@wyeth.com","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Wyeth Research, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028117769","display_name":"Karen L. Marquis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen L. Marquis","raw_affiliation_strings":["Wyeth Research, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102100160","display_name":"HK Lim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"HK Lim","raw_affiliation_strings":["Wyeth Research, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Louis Leung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis Leung","raw_affiliation_strings":["Wyeth Research, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John Kao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Kao","raw_affiliation_strings":["Wyeth Research, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040559866","display_name":"Cynthia Cheesman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia Cheesman","raw_affiliation_strings":["Wyeth Research, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013943246","display_name":"Sharon J. Rosenzweig-Lipson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon Rosenzweig\u2010Lipson","raw_affiliation_strings":["Wyeth Research, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, USA","institution_ids":["https://openalex.org/I4403928396"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5020738134"],"corresponding_institution_ids":["https://openalex.org/I4403928396"],"apc_list":null,"apc_paid":null,"fwci":2.0941,"has_fulltext":false,"cited_by_count":79,"citation_normalized_percentile":{"value":0.85679551,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"12","issue":"3-4","first_page":"167","last_page":"177"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9580000042915344,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9580000042915344,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.010900000110268593,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht2c-receptor-agonist","display_name":"5-HT2C receptor agonist","score":0.9200000166893005},{"id":"https://openalex.org/keywords/serotonin-receptor-pharmacology","display_name":"serotonin receptor pharmacology","score":0.7080000042915344},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9729999899864197},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.7170000076293945},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9359999895095825},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8009999990463257},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9610000252723694},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.7429999709129333},{"id":"https://openalex.org/keywords/migraine","display_name":"migraine","score":0.8560000061988831},{"id":"https://openalex.org/keywords/erectile-dysfunction","display_name":"erectile dysfunction","score":0.9769999980926514},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7096402645111084},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7005990147590637},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.563241183757782},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5307683348655701},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.519666314125061},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4812864661216736},{"id":"https://openalex.org/C2780632750","wikidata":"https://www.wikidata.org/wiki/Q18027437","display_name":"5-HT2C receptor","level":5,"score":0.47289788722991943},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4654453694820404},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4366541802883148},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3914152681827545},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.37584003806114197},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.3098776340484619},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2813875079154968},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.23158571124076843},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.1404261589050293},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004435","descriptor_name":"Eating","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D058826","descriptor_name":"Serotonin 5-HT2 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1527-3458.2006.00167.x","doi":"https://doi.org/10.1111/j.1527-3458.2006.00167.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1527-3458.2006.00167.x","pdf_url":null,"source":{"id":"https://openalex.org/S165828461","display_name":"CNS Drug Reviews","issn_l":"1080-563X","issn":["1080-563X","1527-3458"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drug Reviews","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6506193","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6506193","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drug Rev","raw_type":"Text"},{"id":"pmid:17227285","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17227285","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS drug reviews","raw_type":"Evaluation Study"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:6506193","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6506193","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drug Rev","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1554938697","https://openalex.org/W1798489567","https://openalex.org/W1965454331","https://openalex.org/W1982957594","https://openalex.org/W1992462988","https://openalex.org/W1993266955","https://openalex.org/W2001736388","https://openalex.org/W2002212385","https://openalex.org/W2005128569","https://openalex.org/W2038500073","https://openalex.org/W2038946536","https://openalex.org/W2039160653","https://openalex.org/W2047476622","https://openalex.org/W2048508641","https://openalex.org/W2049691045","https://openalex.org/W2051843225","https://openalex.org/W2059279128","https://openalex.org/W2065982025","https://openalex.org/W2070290419","https://openalex.org/W2076547272","https://openalex.org/W2077466070","https://openalex.org/W2077483764","https://openalex.org/W2081407457","https://openalex.org/W2081780864","https://openalex.org/W2083974470","https://openalex.org/W2085829376","https://openalex.org/W2091064555","https://openalex.org/W2092630281","https://openalex.org/W2094286702","https://openalex.org/W2100572873","https://openalex.org/W2109141033","https://openalex.org/W2129406263","https://openalex.org/W2173814407"],"related_works":["https://openalex.org/W2109141033","https://openalex.org/W1798489567","https://openalex.org/W1993266955","https://openalex.org/W2941553799","https://openalex.org/W2576089858","https://openalex.org/W2173814407","https://openalex.org/W4236682986","https://openalex.org/W4285245594","https://openalex.org/W1992400380","https://openalex.org/W1823516397"],"abstract_inverted_index":{"The":[0],"5-HT(2C)":[1,53],"receptor":[2,54],"subtype":[3],"has":[4,29],"been":[5],"implicated":[6],"in":[7,63,76],"a":[8,27,34,51,59],"wide":[9],"variety":[10],"of":[11,48,79],"conditions":[12],"including":[13],"obesity,":[14,64,80],"anxiety,":[15],"depression,":[16],"obsessive":[17],"compulsive":[18],"disorder,":[19],"schizophrenia,":[20],"migraine":[21],"and":[22,25,45,66],"erectile":[23],"dysfunction":[24],"as":[26,33],"consequence":[28],"received":[30],"considerable":[31],"attention":[32],"target":[35],"for":[36],"drug":[37],"discovery.":[38],"Here":[39],"we":[40],"review":[41],"the":[42],"pharmacological,":[43],"pharmacokinetic":[44],"toxicological":[46],"profile":[47],"WAY-163909":[49,68],"{(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole},":[50],"novel":[52],"selective":[55],"agonist.":[56],"Consistent":[57],"with":[58],"potential":[60],"therapeutic":[61],"utility":[62],"schizophrenia":[65],"depression":[67],"was":[69],"found":[70],"to":[71],"have":[72],"robust":[73],"dose-dependent":[74],"effects":[75],"animal":[77],"models":[78],"psychotic-like":[81],"behavior":[82],"or":[83],"depression.":[84]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}